{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:34:10Z","timestamp":1775190850025,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA259307"],"award-info":[{"award-number":["R01CA259307"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40615-022-01500-6","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:29:42Z","timestamp":1672774182000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differential Profile of Primary and Recurrent Ameloblastomas Among Afro-descendants and Non-Afro-descendants\u2014a Systematic Review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-0031","authenticated-orcid":false,"given":"Parth","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-4966","authenticated-orcid":false,"given":"Olajumoke A.","family":"Effiom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-107X","authenticated-orcid":false,"given":"Abdul-Warith O.","family":"Akinshipo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3090-1374","authenticated-orcid":false,"given":"Sunday O.","family":"Akintoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"3","key":"1500_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/odi.12646","volume":"24","author":"OA Effiom","year":"2018","unstructured":"Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Review of Oral Dis. 2018;24(3):307\u201316. https:\/\/doi.org\/10.1111\/odi.12646.","journal-title":"Review of Oral Dis"},{"issue":"7","key":"1500_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jcms.2009.05.001","volume":"37","author":"C Escande","year":"2009","unstructured":"Escande C, Chaine A, Menard P, Ernenwein D, Ghoul S, Bouattour A, Berdal A, Bertrand JC, Ruhin-Poncet B. A treatment algorithm for adult ameloblastomas according to the Pitie-Salpetriere Hospital experience. Rev J Craniomaxillofac Surg. 2009;37(7):363\u20139. https:\/\/doi.org\/10.1016\/j.jcms.2009.05.001.","journal-title":"Rev J Craniomaxillofac Surg"},{"issue":"3","key":"1500_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4132\/KoreanJPathol.2013.47.3.191","volume":"47","author":"SK Lee","year":"2013","unstructured":"Lee SK, Kim YS. Current concepts and occurrence of epithelial odontogenic tumors: I Ameloblastoma and adenomatoid odontogenic tumor. Review of Korean J Pathol. 2013;47(3):191\u2013202. https:\/\/doi.org\/10.4132\/KoreanJPathol.2013.47.3.191.","journal-title":"Review of Korean J Pathol"},{"issue":"1","key":"1500_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12105-017-0794-1","volume":"11","author":"JM Wright","year":"2017","unstructured":"Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours Odontogenic and Maxillofacial Bone Tumors. Rev Head Neck Pathol. 2017;11(1):68\u201377.","journal-title":"Rev Head Neck Pathol"},{"issue":"8","key":"1500_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ijom.2009.02.018","volume":"38","author":"MA Pogrel","year":"2009","unstructured":"Pogrel MA, Montes DM. Is there a role for enucleation in the management of ameloblastoma? Review of. Int J Oral Maxillofac Surg. 2009;38(8):807\u201312. https:\/\/doi.org\/10.1016\/j.ijom.2009.02.018.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"1500_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijom.2015.12.016","volume":"45","author":"A Almeida Rde","year":"2016","unstructured":"Almeida Rde A, Andrade ES, Barbalho JC, Vajgel A, Vasconcelos BC. Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis. Rev Int J Oral Maxillofac Surg. 2016;45(3):359\u201367.","journal-title":"Rev Int J Oral Maxillofac Surg"},{"issue":"2","key":"1500_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3892\/etm.2013.1165","volume":"6","author":"P Infante-Cossio","year":"2013","unstructured":"Infante-Cossio P, Prats-Golczer V, Gonzalez-Perez LM, Belmonte-Caro R, Martinez DEFR, Torres-Carranza E, Gacto-Sanchez P, Gomez-Cia T. Treatment of recurrent mandibular ameloblastoma. Review of Exp Ther Med. 2013;6(2):579\u201383. https:\/\/doi.org\/10.3892\/etm.2013.1165.","journal-title":"Review of Exp Ther Med"},{"issue":"10","key":"1500_CR8","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.oraloncology.2015.07.010","volume":"51","author":"P Brunner","year":"2015","unstructured":"Brunner P, Bihl M, Jundt G, Baumhoer D, Hoeller S. BRAF pV600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology. Review of Oral Oncol. 2015;51(10):e77\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.07.010.","journal-title":"Review of. Oral Oncol"},{"issue":"11","key":"1500_CR9","first-page":"10","volume":"9","author":"P Mishra","year":"2015","unstructured":"Mishra P, Panda A, Bandyopadhyay A, Kumar H, Mohiddin G. Sonic Hedgehog Signalling Pathway and Ameloblastoma - A Review. Review of J Clin Diagn Res. 2015;9(11):10\u20133.","journal-title":"Review of J Clin Diagn Res"},{"issue":"5","key":"1500_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/path.4317","volume":"232","author":"KJ Kurppa","year":"2014","unstructured":"Kurppa KJ, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. High frequency of BRAF V600E mutations in ameloblastoma. Review of J Pathol. 2014;232(5):492\u20138. https:\/\/doi.org\/10.1002\/path.4317.","journal-title":"Review of J Pathol"},{"issue":"1","key":"1500_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41368-022-00170-8","volume":"14","author":"L Togni","year":"2022","unstructured":"Togni L, Zizzi A, Mazzucchelli R, Santarelli A, Rubini C, Mascitti M. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis. Rev Int J Oral Sci. 2022;14(1):22. https:\/\/doi.org\/10.1038\/s41368-022-00170-8.","journal-title":"Rev Int J Oral Sci"},{"issue":"7","key":"1500_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00405-015-3631-8","volume":"273","author":"AC McClary","year":"2016","unstructured":"McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, Sunwoo J, Colevas AD, Sirjani D. Ameloblastoma: a clinical review and trends in management. Rev Eur Arch Otorhinolaryngol. 2016;273(7):1649\u201361. https:\/\/doi.org\/10.1007\/s00405-015-3631-8.","journal-title":"Rev Eur Arch Otorhinolaryngol"},{"issue":"4","key":"1500_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-0528.1978.tb01149.x","volume":"6","author":"M Shear","year":"1978","unstructured":"Shear M, Singh S. Age-standardized incidence rates of ameloblastoma and dentigerous cyst on the Witwatersrand, South Africa. Rev Commu Dent Oral Epidemiol. 1978;6(4):195\u20139. https:\/\/doi.org\/10.1111\/j.1600-0528.1978.tb01149.x.","journal-title":"Rev Commu Dent Oral Epidemiol"},{"key":"1500_CR14","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Review of BMJ. 2009;339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535.","journal-title":"Review of BMJ"},{"key":"1500_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"Rev BMJ"},{"issue":"1","key":"1500_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13643-018-0699-4","volume":"7","author":"MJ Page","year":"2018","unstructured":"Page MJ, Shamseer L, Tricco AC. Registration of systematic reviews in PROSPERO: 30,000 records and counting. Rev Syst Rev. 2018;7(1):32. https:\/\/doi.org\/10.1186\/s13643-018-0699-4.","journal-title":"Rev Syst Rev"},{"issue":"Pt 1","key":"1500_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.envint.2018.07.015","volume":"121","author":"RL Morgan","year":"2018","unstructured":"Morgan RL, Whaley P, Thayer KA, Schunemann HJ. Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Rev Environ Int. 2018;121(Pt 1):1027\u201331. https:\/\/doi.org\/10.1016\/j.envint.2018.07.015.","journal-title":"Rev Environ Int"},{"issue":"7650","key":"1500_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Rev BMJ. 2008;336(7650):924\u20136.","journal-title":"Rev BMJ"},{"issue":"1","key":"1500_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1037\/amp0000151","volume":"73","author":"HM Levitt","year":"2018","unstructured":"Levitt HM, Bamberg M, Creswell JW, Frost DM, Josselson R, Suarez-Orozco C. Journal article reporting standards for qualitative primary, qualitative meta-analytic, and mixed methods research in psychology: The APA Publications and Communications Board task force report. Review of Am Psychol. 2018;73(1):26\u201346. https:\/\/doi.org\/10.1037\/amp0000151.","journal-title":"Review of Am Psychol"},{"issue":"6","key":"1500_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/rnj.0000000000000281","volume":"45","author":"LL Pierce","year":"2020","unstructured":"Pierce LL. Flattening the learning curve: notable updates in the Publication Manual of the American Psychological Association 7th Edition. Rev Rehabil Nurs. 2020;45(6):309\u201310.","journal-title":"Rev Rehabil Nurs"},{"issue":"1","key":"1500_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13256-019-2140-6","volume":"13","author":"M Broudic-Guibert","year":"2019","unstructured":"Broudic-Guibert M, Blay JY, Vazquez L, Evrard A, Karanian M, Taieb S, Hoog-Labouret N, Oukhatar CMA, Boustany-Grenier R, Arnaud A. Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report. Review of J Med Case Rep. 2019;13(1):245. https:\/\/doi.org\/10.1186\/s13256-019-2140-6.","journal-title":"Review of J Med Case Rep"},{"issue":"1\u20132","key":"1500_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/odi.12702","volume":"24","author":"M Kreppel","year":"2018","unstructured":"Kreppel M, Zoller J. Ameloblastoma-Clinical, radiological, and therapeutic findings. Rev Oral Dis. 2018;24(1\u20132):63\u20136. https:\/\/doi.org\/10.1111\/odi.12702.","journal-title":"Rev Oral Dis"},{"key":"1500_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780199697786.001.0001","volume-title":"Soames\u2019 and Southam's Oral Pathology","author":"M Robinson","year":"2018","unstructured":"Robinson M, Hunter K, Pemberton M, Sloan P. Soames\u2019 and Southam\u2019s Oral Pathology. 5th ed. UK: Oxford University Press; 2018.","edition":"5"},{"issue":"3","key":"1500_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.21147\/j.issn.1000-9604.2017.03.04","volume":"29","author":"R Yang","year":"2017","unstructured":"Yang R, Liu Z, Gokavarapu S, Peng C, Ji T, Cao W. Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma. Rev Chin J Cancer Res. 2017;29(3):189\u201395.","journal-title":"Rev Chin J Cancer Res"},{"issue":"1","key":"1500_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s42047-019-0041-z","volume":"2","author":"AMH Cadavid","year":"2019","unstructured":"Cadavid AMH, Araujo JP, Coutinho-Camillo CM, Bologna S, Junior CAL, Louren\u00e7o SV. Ameloblastomas: current aspects of the new WHO classification in an analysis of 136 cases. Rev Surg Exp Pathol. 2019;2(1):17. https:\/\/doi.org\/10.1186\/s42047-019-0041-z.","journal-title":"Rev Surg Exp Pathol"},{"key":"1500_CR26","doi-asserted-by":"crossref","unstructured":"Ajila V, and Hegde S. 2022. Ameloblastomas vs recurrent ameloblastomas: a systematic review. Review of. J Oral Med Oral Surg 28 (1).","DOI":"10.1051\/mbcb\/2021044"},{"issue":"3","key":"1500_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4103\/jomfp.JOMFP_174_17","volume":"22","author":"PM Shirsat","year":"2018","unstructured":"Shirsat PM, Bansal S, Prasad P, Desai RS. Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: An institutional study. Rev J Oral Maxillofac Pathol. 2018;22(3):353\u20139. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_174_17.","journal-title":"Rev J Oral Maxillofac Pathol"},{"issue":"4","key":"1500_CR28","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.4317\/medoral.23519","volume":"25","author":"S Derakhshan","year":"2020","unstructured":"Derakhshan S, Aminishakib P, Karimi A, Saffar H, Abdollahi A, Mohammadpour H, KharaziFard MJ, Memarha A. High frequency of BRAF V600E mutation in Iranian population ameloblastomas. Rev Med Oral Patol Oral Cir Bucal. 2020;25(4):e502\u20137. https:\/\/doi.org\/10.4317\/medoral.23519.","journal-title":"Rev Med Oral Patol Oral Cir Bucal"},{"issue":"5","key":"1500_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jop.12851","volume":"48","author":"KY Oh","year":"2019","unstructured":"Oh KY, Cho SD, Yoon HJ, Lee JI, Ahn SH, Hong SD. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial-mesenchymal transition. Rev J Oral Pathol Med. 2019;48(5):413\u201320. https:\/\/doi.org\/10.1111\/jop.12851.","journal-title":"Rev J Oral Pathol Med"},{"issue":"1","key":"1500_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tripleo.2010.01.024","volume":"110","author":"JJ Sauk","year":"2010","unstructured":"Sauk JJ, Nikitakis NG, Scheper MA. Are we on the brink of nonsurgical treatment for ameloblastoma? Review of. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(1):68\u201378. https:\/\/doi.org\/10.1016\/j.tripleo.2010.01.024.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"1500_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/jop.12807","volume":"48","author":"Z You","year":"2019","unstructured":"You Z, Liu SP, Du J, Wu YH, Zhang SZ. Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review. Rev J Oral Pathol Med. 2019;48(3):201\u20135. https:\/\/doi.org\/10.1111\/jop.12807.","journal-title":"Rev J Oral Pathol Med"},{"issue":"1","key":"1500_CR32","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.oooo.2015.12.016","volume":"122","author":"S Tan","year":"2016","unstructured":"Tan S, Pollack JR, Kaplan MJ, Colevas AD, West RB. BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response. Rev Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(1):e5-7.","journal-title":"Rev Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-022-01500-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-022-01500-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-022-01500-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T15:35:30Z","timestamp":1704900930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-022-01500-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1007\/s40615-022-01500-6","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}